Metabolic Syndrome and Long-term Survival Following Liver Resection
NCT05568576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2023-05-06
Summary
Although hepatitis C virus (HCV) infection remains one of the main causes of hepatocellular carcinoma (HCC) worldwide, metabolic syndrome, with its increase in prevalence, has become an important and significant risk factor for HCC
Conditions
- Survival
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Ahmed Shwakt · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-01
- Primary Completion
- 2022-12-30
- Completion
- 2022-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
NCT02031913 ·Status: COMPLETED
-
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation
NCT04455932 ·Status: RECRUITING ·Phase: NA
-
Esophagectomy in Patients With Liver Cirrhosis
NCT04809870 ·Status: COMPLETED
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
NCT05870969 ·Status: RECRUITING
-
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
NCT00629421 ·Status: COMPLETED
-
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma
NCT02526043 ·Status: UNKNOWN ·Phase: NA
-
Enhanced Recovery After Surgery Protocal Versus Traditional Care in Laparoscopic Hepatectomy
NCT02533193 ·Status: COMPLETED ·Phase: NA
-
Metabolic Surgery for Steato-Hepatitis
NCT04282005 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy
NCT07182136 ·Status: COMPLETED
-
Evaluation of Laparoscopic Non Anatomical Liver Resection in Hepatic Pathology
NCT06166511 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study
NCT04329559 ·Status: COMPLETED
-
Association of Hepatitis C Virus With Breast Cancer
NCT04090164 ·Status: COMPLETED
-
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma
NCT02730611 ·Status: COMPLETED
-
Liver Diseases: Extracellular Vesicles as Biomarkers
NCT07185360 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932 ·Status: UNKNOWN
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis
NCT04763707 ·Status: COMPLETED
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease
NCT03307408 ·Status: UNKNOWN
-
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
NCT01350167 ·Status: UNKNOWN ·Phase: NA
-
Laparoscope Anatomical and Aon-anatomical Hepatectomy
NCT02009176 ·Status: UNKNOWN ·Phase: NA
-
Observational Study of Biomarker During Liver Surgery
NCT02102971 ·Status: TERMINATED
-
Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
NCT01768741 ·Status: UNKNOWN ·Phase: NA
-
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
NCT02863757 ·Status: RECRUITING